Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 15, 2020

Presidio Medical raises $30m to develop neuromodulation platform

US-based medical device company Presidio Medical has raised $30m in a funding round led by Invus Opportunities.

US-based medical device company Presidio Medical has raised $30m in a funding round led by Invus Opportunities.

The round was also joined by the company’s existing investor Action Potential Venture Capital.

Presidio Medical plans to use the funds for the development of its neuromodulation technology platform to treat chronic pain.

South San Francisco-based company also plans to expand the platform application to include additional indications.

Presidio Medical’s neuromodulation technology platform offers pain relief across a spectrum of pain types where conventional treatment has failed.

Approximately 50 million people suffer from chronic pain in the US, with treatment and productivity costs often totalling over $500bn each year.

Content from our partners
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

Medications, acupuncture, local electrical and brain stimulation, and surgery are some of the existing treatments for chronic pain. Psychotherapy, relaxation and medication therapies, biofeedback and behaviour modification are also used by physicians to treat the condition.

Unlike normal pain, chronic pains last weeks, months or even years despite treatments.

Patients who fail or receive minimal relief from standard pain treatment represent an important unmet medical need, the company noted.

According to the Centers for Disease Control and Prevention (CDC), despite the mortality associated with opiate use, there were over 168 million opiate prescriptions in the US in 2018.

Invus Opportunities, the lead investor of the round, is a sister fund of the equity investment company The Invus Group. The company leads rounds of financing and co-invests in syndicated financings. It currently manages over $1.5 bn.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU